These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1165736)

  • 21. [Medicated stainless steel ring-165, medicated gamma-intrauterine devices and TCu220C: a multicenter comparative study].
    Zhuang L; Yang B; Yuan H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Feb; 32(2):97-101. PubMed ID: 9596880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A critical ('stress') evaluation of the combined ML Copper 250-short IUD in nulliparous women.
    Goldstuck ND
    Contracept Deliv Syst; 1981 Oct; 2(4):287-93. PubMed ID: 12336989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C.
    Contraception; 1997 Dec; 56(6):341-52. PubMed ID: 9494767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Florida's experience with an intrauterine device for the nulliparous patients.
    Caraway AF
    J Reprod Med; 1975 Sep; 15(3):114-6. PubMed ID: 1214252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Systemic use of paracervical block during the insertion of an I.U.D].
    Amyot-Legault A
    Union Med Can; 1981 Aug; 110(8):721-6. PubMed ID: 7292804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intrauterine contraception from the viewpoint of an ambulatory gynecologic department].
    Hagen P
    Z Arztl Fortbild (Jena); 1981 Sep; 75(17):800-4. PubMed ID: 7345787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between menorrhagia and risk of intrauterine device-related uterine perforation and device expulsion: results from the Association of Uterine Perforation and Expulsion of Intrauterine Device study.
    Getahun D; Fassett MJ; Gatz J; Armstrong MA; Peipert JF; Raine-Bennett T; Reed SD; Zhou X; Schoendorf J; Postlethwaite D; Shi JM; Saltus CW; Wang J; Xie F; Chiu VY; Merchant M; Alabaster A; Ichikawa LE; Hunter S; Im TM; Takhar HS; Ritchey ME; Chillemi G; Pisa F; Asiimwe A; Anthony MS
    Am J Obstet Gynecol; 2022 Jul; 227(1):59.e1-59.e9. PubMed ID: 35292234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Presentation of a new IUD: the "Ombrelle 250"].
    Audebert AJ; Emperaire JC; Larue-charlus S
    Contracept Fertil Sex (Paris); 1985 Sep; 13(9):967-71. PubMed ID: 12267500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of two techniques used in immediate postplacental insertion of TCu 380A intrauterine device: 12 month follow-up of 910 cases].
    Xu J; Zhuang L; Yu G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jun; 32(6):354-7. PubMed ID: 9596916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical experience with Progestasert beyond one year of use.
    Wan LS
    Contracept Deliv Syst; 1981 Jul; 2(3):243-8. PubMed ID: 12278911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Side effects and complications of intrauterine devices with special reference to pelvic infection].
    Marchino GL; Grio R; Garyphallides N; Zaccheo F; Carbone G
    Minerva Ginecol; 1986 Nov; 38(11):953-7. PubMed ID: 3808430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
    Wildemeersch D; Janssens D; Vrijens M; Weyers S
    Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of intra-uterine devices, Copper-T-200 and Dana-Super-Fix-Cuprum (author's transl)].
    Melzer H; Heyer E; Hielscher K; Schneider W
    Zentralbl Gynakol; 1980; 102(22):1283-7. PubMed ID: 7223144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of copper T as contraceptive after caesarean section.
    Parikh V; Gandhi AS
    J Indian Med Assoc; 1989 May; 87(5):113-5. PubMed ID: 2600433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The copper-7 intrauterine contraceptive device: 5-year evaluation.
    Sellors JW
    Can Med Assoc J; 1981 Oct; 125(7):717-20. PubMed ID: 7326653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levonorgestrel intrauterine device: new preparation. An alternative.
    Prescrire Int; 1999 Dec; 8(44):175-7. PubMed ID: 11503815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The clinical efficacy of the copper-containing intrauterine devices Nova T and Copper-T-200 Ag in a randomized study (author's transl)].
    Altmann G; Feichtinger W; Havelec L; Beck A
    Wien Klin Wochenschr; 1981 Sep; 93(17):556-8. PubMed ID: 7303702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Application of intrauterine devices preceded by measurement of the endometrial cavity using a Hollister sound].
    Reynoso Ron L; Lozano Balderas M; Lara Ricalde R; Flores Velez A; Aznar Ramos R
    Ginecol Obstet Mex; 1982 Feb; 50(298):21-4. PubMed ID: 7129181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.